Impact of Delays in Diagnosis on Healthcare Costs Associated With Blastomycosis, Coccidioidomycosis, and Histoplasmosis in a Commercially Insured Population
- 31 July 2025
- journal article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 12 (8)
Abstract
Among patients with blastomycosis (n = 281), coccidioidomycosis (n = 1920), and histoplasmosis (n = 2180), 62% experienced diagnostic delays (mean 29 days). Patients who experienced delays incurred average excess healthcare costs of up to $15 648 (95% confidence interval: $8600–$22 695) compared with those without a delay. Earlier diagnosis may help reduce excess costs.Keywords
This publication has 10 references indexed in Scilit:
- Antifungal therapy patterns, healthcare utilization, costs, and mortality in central nervous system and non-central nervous system disseminated coccidioidomycosis across the continuum-of-careClinical Microbiology and Infection, 2025
- Diagnostic delay in pulmonary blastomycosis: a case series reflecting a referral center experienceInfection, 2022
- Frequency and Duration of, and Risk Factors for, Diagnostic Delays Associated with HistoplasmosisJournal of Fungi, 2022
- Enhanced Surveillance for Histoplasmosis—9 States, 2018–2019Open Forum Infectious Diseases, 2020
- Delays in Coccidioidomycosis Diagnosis and Associated Healthcare Utilization, Tucson, Arizona, USAEmerging Infectious Diseases, 2019
- Delays in Coccidioidomycosis Diagnosis and Relationship to Healthcare Utilization, Phoenix, Arizona, USA 1Emerging Infectious Diseases, 2019
- Histoplasmosis-related Healthcare Use, Diagnosis, and Treatment in a Commercially Insured Population, United StatesClinical Infectious Diseases, 2019
- Enhanced Surveillance for Coccidioidomycosis, 14 US States, 2016Emerging Infectious Diseases, 2018
- Constructing Inverse Probability Weights for Continuous ExposuresEpidemiology, 2014
- Enhanced Surveillance of Coccidioidomycosis, Arizona, USA, 2007–2008Emerging Infectious Diseases, 2010